Eastman Chemical (EMN, Specialty Chemicals) Stock Valuation & Fair Value Fairly valued
Eastman Chemical (EMN, Specialty Chemicals) trades at a blended P/E of 12.2, about 5% above its historical normal valuation, with a forward growth estimate of 10.7% and a PEG of 1.14. Analysts' one-year estimates have been hit 36% of the time.
The Street vs SeerForecast
Wall Street's mean price target for EMN is $81.60 across 15 analysts, 10.1% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been fairly valued since 2026-06-03.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is Eastman Chemical stock overvalued?
At a blended P/E of 12.2 versus its historical normal P/E of 11.6, Eastman Chemical trades about 5% above its typical valuation, with a PEG of 1.14 on 10.7% forward growth. tickerseer currently rates it fairly valued.
What is Eastman Chemical's fair value and PEG?
Eastman Chemical trades at a blended P/E of 12.2 against a historical normal P/E of 11.6, a PEG of 1.14, and a forward growth estimate of 10.7%.
Has tickerseer's rating of Eastman Chemical changed?
tickerseer's rating has been fairly valued since 2026-06-03.
What is the analyst price target for Eastman Chemical?
The mean Wall Street price target for Eastman Chemical is $81.60 across 15 analysts, 10.1% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Specialty Chemicals. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.